Le Lézard
Classified in: Business
Subject: v

Canoe EIT Income Fund Announces Quarterly Distribution on Preferred Units


CALGARY, Alberta, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Canoe EIT Income Fund ("Canoe" or the "Fund")(TSX ? EIT.UN, EIT.PR.A, EIT.PR.B) announces quarterly distribution on preferred units.

Cumulative Redeemable Series 1 and Series 2 Preferred Unit holders will receive a distribution of $0.30 per unit. The distribution will be paid on December 13, 2019 to unitholders of record on November 22, 2019.  The ex-distribution date for this distribution is November 21, 2019

About Canoe EIT Income Fund
One of Canada's largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN, EIT.PR.A and EIT.PR.B; and is actively managed by Robert Taylor, Senior Vice President and Portfolio Manager of Canoe Financial.

About Canoe Financial
Canoe is one of Canada's fastest growing independent mutual fund companies managing over $5.9 billion in assets across a diversified range of award-winning mutual funds and private energy equity products. Founded in 2008, Canoe Financial LP is an employee-owned investment management firm focused on building financial wealth for Canadians. Canoe has offices in Calgary, Toronto, Vancouver, Winnipeg, Ottawa and Montreal.

For further information, please contact:
Investor Relations
1?877?434?2796
www.canoefinancial.com
info@canoefinancial.com

Not for Distribution to U.S. Newswire Services or for Dissemination in the United States of America.

The Fund makes monthly distributions of an amount comprised in whole or in part of Return of Capital (ROC) of the net asset value per unit. A ROC reduces the amount of your original investment and may result in the return to you of the entire amount of your original investment. ROC that is not reinvested will reduce the net asset value of the fund, which could reduce the fund's ability to generate future income. You should not draw any conclusions about the fund's investment performance from the amount of this distribution.

Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the information filed about the fund on www.sedar.com before investing. Investment funds are not guaranteed and past performance may not be repeated.

This communication is not to be construed as a public offering to sell, or a solicitation of an offer to buy securities. Such an offer can only be made by way of a prospectus or other applicable offering document and should be read carefully before making any investment. This release is for information purposes only. Investors should consult their Investment Advisor for details and risk factors regarding specific strategies and various investment products.


These press releases may also interest you

at 03:15
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 ? ALMED ; OTCQX Best Market ?MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiDtm ASI...

at 03:05
E-commerce will continue to play a strong role in the apparel industry's success, particularly while the in-store shopping experience feels different from what consumers are accustomed to. In early June, U.S. consumers told The NPD Group that more...

at 03:01
Groupe Renault and Google Cloud today announced a new industrial and technology partnership to accelerate the digitization of Groupe Renault's industrial system and of Industry 4.0 transformation....

at 03:00
Dutch eyewear brand, Ace & Tate, is leading the industry to be more sustainable and tech-advanced. A recent financial investment of ?14.25 million led by existing investor Rinkelberg Capital LTD, brings the 7-year-old company's total funding to ?57.5...

at 03:00
CEBINA GmbH, an Austrian biotech company, announces positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays. One of these drugs,...

at 03:00
Hondo Enterprises, in partnership with Savills, has become the first and only company in the United Kingdom to utilise the BIOPROTECTUstm system offered by BioSupplies.com, LLC in the United Kingdom. When it is applied to surfaces and spaces, it...



News published on 8 november 2019 at 17:05 and distributed by: